Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen ; volume:18 ; number:1 ; day:20 ; month:6 ; year:2018 ; pages:1-9 ; date:12.2018
BMC ophthalmology ; 18, Heft 1 (20.6.2018), 1-9, 12.2018
- Urheber
-
Lai, Kunbei
- Beteiligte Personen und Organisationen
-
Li, Ying
Zhou, Lijun
Zhong, Xiaojin
Huang, Chuangxin
Xu, Fabao
Lu, Lin
Ge, Jian
Jin, Chenjin
SpringerLink (Online service)
- DOI
-
10.1186/s12886-018-0801-7
- URN
-
urn:nbn:de:101:1-2018083022295003344852
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lai, Kunbei
- Li, Ying
- Zhou, Lijun
- Zhong, Xiaojin
- Huang, Chuangxin
- Xu, Fabao
- Lu, Lin
- Ge, Jian
- Jin, Chenjin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Delay-induced oscillation phenomenon of a delayed finance model in enterprise operation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Manufacturable pattern collage along a boundary
Idiopathic pigmented vitreous cyst without autofluorescence: a case report
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Delay-induced oscillation phenomenon of a delayed finance model in enterprise operation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Manufacturable pattern collage along a boundary
Idiopathic pigmented vitreous cyst without autofluorescence: a case report
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Delay-induced oscillation phenomenon of a delayed finance model in enterprise operation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Manufacturable pattern collage along a boundary
Idiopathic pigmented vitreous cyst without autofluorescence: a case report
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy